Cargando…

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance

Objective: Stereotactic body radiotherapy (SBRT) is increasingly used to treat a variety of tumors, including head and neck squamous cell carcinoma (HNSCC) in the recurrent setting. While there are published data for re-irradiation using SBRT for HNSCC, there are limited data supporting its use as u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amini, Arya, McDermott, Jessica D., Gan, Gregory, Bhatia, Shilpa, Sumner, Whitney, Fisher, Christine M., Jimeno, Antonio, Bowles, Daniel W., Raben, David, Karam, Sana D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189612/ https://www.ncbi.nlm.nih.gov/pubmed/25340041 http://dx.doi.org/10.3389/fonc.2014.00274

Ejemplares similares

Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy
por: Sumner, Whitney A., et al.
Publicado: (2017)

Stereotactic Body Radiation Therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review
por: Amini, Arya, et al.
Publicado: (2014)

Overcoming Resistance to Immunotherapy in Head and Neck Cancer Using Radiation: A Review
por: Hui, Caressa, et al.
Publicado: (2021)

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas
por: Bhatia, Shilpa, et al.
Publicado: (2016)

Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT)
por: Altoos, Basel, et al.
Publicado: (2015)

IMRT with Stereotactic Body Radiotherapy Boost for High Risk Malignant Salivary Gland Malignancies: A Case Series
por: Karam, Sana D., et al.
Publicado: (2014)

Durable Control and Overall Survival Benefit with Focal Reirradiation in Cervical Cancer
por: Amini, Arya, et al.
Publicado: (2015)

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins
por: Amini, Arya, et al.
Publicado: (2019)

Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy
por: Ray, Xenia, et al.
Publicado: (2021)

Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma
por: Combs, Stephanie E, et al.
Publicado: (2007)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2017)

Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer
por: Stanisce, Luke, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers
por: Anand, Anil Kumar, et al.
Publicado: (2020)

Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
por: Yamazaki, Hideya, et al.
Publicado: (2016)

Techniques for the Application of Stereotactic Head Frames Based on a 25-Year Experience
por: Safaee, Michael, et al.
Publicado: (2016)

Radiation shielding for gamma stereotactic radiosurgery units
por: McDermott, Patrick N.
Publicado: (2007)

Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer
por: Vargo, John A., et al.
Publicado: (2014)

High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
por: Polanowski, Paweł, et al.
Publicado: (2022)

Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
por: Huang, Tai-Lin, et al.
Publicado: (2022)

Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy
por: Kamogawa, Misaki, et al.
Publicado: (2022)

Population-level and individual-level explainers for propensity score matching in observational studies
por: Ghosh, Debashis, et al.
Publicado: (2022)

Monte Carlo evaluation of tissue heterogeneities corrections in the treatment of head and neck cancer patients using stereotactic radiotherapy
por: Pokhrel, Damodar, et al.
Publicado: (2016)

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
por: Bahig, Houda, et al.
Publicado: (2019)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
por: Darragh, Laurel B., et al.
Publicado: (2022)

Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC
por: Darragh, Laurel B., et al.
Publicado: (2022)

Stereotactic Radiotherapy for Oligometastasis
por: Otake, Sotaro, et al.
Publicado: (2019)

Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

Prediction of conical collimator collision for stereotactic radiosurgery
por: Park, Jeonghoon, et al.
Publicado: (2020)

RADI-11. Evaluating the Tissue Effects of Dose-escalated Pre-operative Stereotactic Radiotherapy for Resectable Brain Metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Guided imagery for treatment (GIFT): protocol of a pilot trial of guided imagery versus treatment as usual to address radiotherapy-related distress in head and neck cancer
por: Kolva, Elissa, et al.
Publicado: (2022)

Stereotactic Radiation Therapy for De Novo Head and Neck Cancers: A Systematic Review and Meta-Analysis
por: Malik, Nauman H., et al.
Publicado: (2020)

Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
por: Endo, Masashi, et al.
Publicado: (2023)

Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2022)

Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer
por: Gadwa, Jacob, et al.
Publicado: (2021)

Stereotactic Radiosurgery in a Small Cell Lung Cancer Patient With Numerous Brain Metastases
por: Lian, Andrew, et al.
Publicado: (2022)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_si2hlv38boeke57tt33m6dcioj